The last decade has witnessed a global expansion in the diagnosis and management of patients with chronic thromboembolic disease. This has been fueled by a number of new treatment modalities which have shown considerable promise, particularly in inoperable CTEPH patients. This webinar, presented by leading experts in the field, will address some of the most frequently asked questions by clinicians providing care to this unique patient group.
 

Scientific Program

Moderator:
William Auger, MD

Welcome and Introductions
William Auger, MD, UCSD, San Diego, CA, USA

The Prevalence of CTED and CTEPH Around the World: What Do We Need To Do To Figure This Out?
Frederikus Klok, MD, Leiden University, Leiden, Netherlands

Pulmonary Endarterectomy: Challenges After Previous Failed BPA Sessions
Michael Madani, MD, UCSD, San Diego, CA, USA

Can CTEPH Be Cured with Surgery? The Unknowns of Anticoagulation, Recurrence, and Persistence
Joanna Pepke-Zaba, MD, Papworth Hospital, Cambridge, UK

Live Q&A Segment with All Speakers
Led by Moderator

ISHLT Announcements
Greg Schultz, ISHLT CEO
 

Continuing Education Information

There will be no continuing education available for this webinar.